Search > Plaque Psoriasis
My employer runs this trial

ORKA-002 for Plaque Psoriasis

(ORKA-002-213 Trial)

Enrolling by invitation at 7 trial locations
Age: 18+
Sex: Any
Trial Phase: Phase 2
Sponsor: Oruka Therapeutics, Inc.
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

An open-label study with maintenance dosing to evaluate the long-term safety and efficacy of ORKA-002 in adult participants with moderate-to-severe plaque psoriasis, who previously participated in an Oruka Therapeutics sponsored study.

Are You a Good Fit for This Trial?

This trial is for adults with moderate-to-severe plaque psoriasis who have already taken part in a previous Oruka Therapeutics study. Participants must meet certain health requirements set by the researchers.

Inclusion Criteria

For women of childbearing potential and fertile male participants with a partner of childbearing potential must be willing to continue to use highly effective contraception
Participants who have successfully completed the preceding trial
Signed informed consent by participants from previous trial choosing to transition into the Open-label study
See 1 more

Exclusion Criteria

Participants whom the Investigator feels would not benefit from treatment with open-label ORKA-002
I did not have serious side effects from ORKA-002 that stopped my treatment before.
Participant is pregnant or breastfeeding
See 3 more

What Are the Treatments Tested in This Trial?

Interventions

  • ORKA-002

Trial Overview

The study is testing long-term safety and effectiveness of ORKA-002, given as ongoing maintenance treatment to people with plaque psoriasis. All participants receive the same treatment (no placebo).

How Is the Trial Designed?

3

Treatment groups

Experimental Treatment

Group I: ORKA-002 (Mid-Dose)Experimental Treatment1 Intervention
Group II: ORKA-002 (Low Dose)Experimental Treatment1 Intervention
Group III: ORKA-002 (High Dose)Experimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Oruka Therapeutics, Inc.

Lead Sponsor

Trials
1
Recruited
20+

Unbiased Results

We believe in providing patients with all the options.

Your Data Stays Your Data

We only share your information with the clinical trials you're trying to access.

Verified Trials Only

All of our trials are run by licensed doctors, researchers, and healthcare companies.